Last reviewed · How we verify
Erosive Esophagitis in Pediatric Patients 1 to 11 Years Old
Approved treatments
- Rabeprazole 40 mg · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Erosive Esophagitis in Pediatric Patients 1 to 11 Years Old patent landscape — cliff calendar, originator estates, attackable patents
- Erosive Esophagitis in Pediatric Patients 1 to 11 Years Old treatment landscape brief
- Erosive Esophagitis in Pediatric Patients 1 to 11 Years Old treatment updates RSS
Frequently asked questions about Erosive Esophagitis in Pediatric Patients 1 to 11 Years Old
What drugs treat Erosive Esophagitis in Pediatric Patients 1 to 11 Years Old?
Tracked treatments include Rabeprazole 40 mg.
What is the treatment for Erosive Esophagitis in Pediatric Patients 1 to 11 Years Old?
Standard treatment for Erosive Esophagitis in Pediatric Patients 1 to 11 Years Old includes Rabeprazole 40 mg. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Erosive Esophagitis in Pediatric Patients 1 to 11 Years Old patent cliff · Erosive Esophagitis in Pediatric Patients 1 to 11 Years Old CI report
- Treatment: Rabeprazole 40 mg · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing